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Background: High-throughput sequencing technologies, such as the Illumina Genome Analyzer, are powerful new
tools for investigating a wide range of biological and medical questions. Statistical and computational methods are
key for drawing meaningful and accurate conclusions from the massive and complex datasets generated by the
sequencers. We provide a detailed evaluation of statistical methods for normalization and differential expression
(DE) analysis of Illumina transcriptome sequencing (mRNA-Seq) data.
Results: We compare statistical methods for detecting genes that are significantly DE between two types of
biological samples and find that there are substantial differences in how the test statistics handle low-count genes.
We evaluate how DE results are affected by features of the sequencing platform, such as, varying gene lengths,
base-calling calibration method (with and without phi X control lane), and flow-cell/library preparation effects. We
investigate the impact of the read count normalization method on DE results and show that the standard
approach of scaling by total lane counts (e.g., RPKM) can bias estimates of DE. We propose more general quantile-
based normalization procedures and demonstrate an improvement in DE detection.
Conclusions: Our results have significant practical and methodological implications for the design and analysis of
mRNA-Seq experiments. They highlight the importance of appropriate statistical methods for normalization and DE
inference, to account for features of the sequencing platform that could impact the accuracy of results. They also
reveal the need for further research in the development of statistical and computational methods for mRNA-Seq.
Background
For the past decade, microarrays have been the assays of
choice for high-throughput studies of gene expression.
Recent improvements in the efficiency, quality, and cost
of genome-wide sequencing have prompted biologists to
rapidly abandon microarrays in favor of ultra high-
throughput sequencing, a.k.a., second-generation or
next-generation sequencing: e.g., Applied Biosystems’
SOLiD, Helicos BioSciences’ HeliScope, Illumina’sG e n -
ome Analyzer, and Roche’s 454 Life Sciences sequencing
systems. These high-throughput sequencing technologies
have already been applied to monitor genome-wide
transcription levels (mRNA-Seq), DNA-protein interac-
tions (ChIP-Seq), chromatin structure, and DNA methy-
lation [1-9].
We evaluate statistical methods for the inference of dif-
ferential expression (DE) with mRNA-Seq, using refer-
ence samples from the MicroArray Quality Control
(MAQC) Project [10]. With corresponding quantitative
real-time polymerase chain reaction (qRT-PCR) data on
roughly one thousand genes, we compare different nor-
malization and DE procedures and assess possible biases
related to the sequencing technology. For genes that are
well-expressed in both samples being compared, the
examined tests (Fisher’s exact test and GLM-based tests)
are indistinguishable. However, substantial differences
exist in their ability to give reliable DE estimates when
even just one of the samples yields low read counts (e.g.,
≤ 10). One inherent bias of the Illumina platform is the
preferential sequencing of longer genes [11]. With the
tests considered here, longer genes are more likely
declared DE. We demonstrate that weighting the DE sta-
tistics by gene length can mitigate this effect.
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observed due to differences in flow-cells/library prepara-
tions, we show that these do not impact substantially
the differential expression calls for the MAQC dataset.
We also find that not using the standard phi X control
lane in each flow-cell, as in the base-calling calibration
procedure recommended by Illumina, does not nega-
tively impact DE detection. Moreover, auto-calibration
without the phi X lane increases both quantity and qual-
ity of mapped reads. In this regard, there is no obvious
benefit in using a phi X lane; doing away with such a
control lane leads to more balanced and cost-effective
designs.
We demonstrate that the greatest impact on DE
detection is the choice of normalization procedure. As
different lanes have different total read counts, i.e.,
sequencing depths, the usual approach is to scale gene
counts within each lane by the total lane count: e.g., the
now standard reads per kilobase of exon model per mil-
lion mapped reads (RPKM) of [7] or the hypergeometric
model of [6]. We show that this form of global normali-
zation is heavily affected by a relatively small proportion
of highly-expressed genes and, as such, can give biased
estimates of DE if these few genes are differentially
expressed across the conditions under comparison. We
propose alternative more robust quantile-based normali-




This article considers two mRNA-Seq datasets related to
the MicroArray Quality Control Project [10] and
obtained using Illumina’sG e n o m eA n a l y z e rI Ih i g h -
throughput sequencing system [12]. The experiments
analyze two biological samples: Ambion’s human brain
reference RNA and Stratagene’s human universal refer-
ence RNA, herein referred to as Brain and UHR,
respectively.
In the first experiment (MAQC-2), two types of biolo-
gical samples (Brain and UHR) were assayed, each using
seven lanes distributed across two flow-cells. One library
preparation was used for each of the two types of biolo-
gical samples. Thus, biological effects are confounded
with library preparation effects, i.e., some differences in
mRNA-Seq measures between Brain and UHR could be
due only to experimental artifacts. In the second experi-
ment (MAQC-3), four different UHR library prepara-
tions were assayed using 14 lanes from two flow-cells;
each library preparation was assayed on only one of the
flow-cells. Thus, library preparation effects are nested
within flow-cell effects and differences between flow-
cells are confounded with library preparation effects (see
[Additional file 1: Supplemental Figure S1] for the
experimental design). Sequencing reads from both
MAQC-2 and MAQC-3 experiments have been depos-
ited to the short-read archive under the accession num-
ber, SRA010153.1.
As part of the original MAQC Project, around one
thousand genes were also chosen to be assayed by
qRT-PCR [13]. We use these qRT-PCR data as a gold-
standard to benchmark the gene expression values
determined by mRNA-Seq. Additionally, a large num-
ber of microarray experiments were conducted. We
compare the mRNA-Seq measures to those derived
from a set of Affymetrix Human Genome U133 Plus
2.0 arrays (GSE5350, samples AFX_1_ [A-B] [1-5]; see
[Additional file 2: Supplemental Sections S1.2 and
S1.2] for details on qRT-PCR and array analysis).
Overview of the Illumina sequencing platform
We give a brief, non-technical overview of the steps
involved in an Illumina mRNA-Seq experiment [12]. A
sample of interest undergoes library preparation, a series
of steps to convert the input RNA into small fragments
of DNA that can be sequenced by the Illumina machine.
Specifically, starting with any total RNA sample, Illumi-
na’s mRNA-Seq library preparation protocol includes
poly-A RNA isolation, RNA fragmentation, reverse tran-
scription to cDNA using random primers, adapter liga-
tion, size-selection from a gel, and PCR enrichment
[[14], Figure six]. The resulting cDNA library is placed
in one of the eight lanes of a flow-cell. Individual cDNA
fragments attach to the surface of the lane and subse-
quently undergo an amplification step, whereby they are
converted into clusters of double-stranded DNA. The
flow-cell is then placed in the sequencing machine,
where each cluster is sequenced in parallel. Specifically,
at each cycle, the four fluorescently labeled nucleotides
are added and the signals emitted at each cluster
recorded. For each flow-cell, this process is repeated for
a given number of cycles, e.g., 35 cycles in the MAQC
experiments. The fluorescence intensities are then con-
verted into base-calls. The number of cycles determines
the length of the reads; the number of clusters deter-
mines the number of reads.
Pre-processing of sequencing data
For the two MAQC experiments, 35 base-pair-long
reads were obtained using Illumina’s standard Genome
Analyzer pre-processing pipeline, Version 1.3 [12,15].
We used Bowtie to map reads to the genome (GRCh37
assembly) [16].
Illumina’s default base-calling algorithm, Bustard, can
be calibrated in two ways. The method recommended
by Illumina is to reserve one lane per flow-cell for
sequencing DNA (typically phi X DNA) and use data
from this control lane to determine base-calls and
Bullard et al. BMC Bioinformatics 2010, 11:94
http://www.biomedcentral.com/1471-2105/11/94
Page 2 of 13quality scores for the other seven lanes [[15], Supple-
mentary Information, p. 7]. Bustard can also be run
using the auto-calibration method, which scores base-
calls in a manner similar to the phred base-caller [17]
and does not require a control lane per flow-cell. In
both MAQC experiments, one lane of each flow-cell
was reserved for sequencing phi X genomic DNA. For
one experiment (MAQC-2), we obtained both auto-cali-
brated and phi X-calibrated reads.
Except for the section discussing the impact of base-
calling calibration method, we focus on phi X-calibrated,
purity-filtered reads that map uniquely to the genome,
with up to two mismatches. The restriction to reads
mapping to the genome implies that exon-exon junction
reads are excluded (~10% of the reads). Additionally,
the library preparation protocol does not allow consid-
eration of strand-specific counts, so reads mapping to
the forward and reverse strands are pooled.
Definition of union-intersection genes
In our evaluation of DE, we focus on overall expression
of a gene, rather than isoform-specific expression. There
is no standard technique for summarizing expression
levels of genes with several isoforms (see, for example,
[6] and [7] for different approaches). For a given gene,
we first define a constitutive exon as a set of consecutive
exonic bases (i.e., portion of or entire exon) that belong
to each isoform of the gene. We then define a union-
intersection (UI) gene as a composite gene-level region
of interest consisting of the union of constitutive exons
that do not overlap with coding exons of other genes
(based on Ensembl, Version 55; see [Additional file 2:
Supplemental Section S2]). We retain all genes identified
with chromosomes 1-22, X, and Y. In addition to
including protein-coding genes, the UI genes represent a
number of other classes of Ensembl annotation, such as
pseudogenes and small RNAs.
Normalization
In order to derive gene expression measures and com-
pare these measures between (groups of) lanes, one first
needs to normalize read counts to adjust for varying
lane sequencing depths and potentially other technical
effects. All but one of the normalization methods con-
sidered here are global procedures, in the sense that
o n l yas i n g l ef a c t o rdi is used to scale the counts (per-
lane).
We evaluate three types of global normalizations: (1)
total lane counts, as in RPKM of [7], (2) per-lane counts
for a “housekeeping” gene expected to be constantly
expressed across biological conditions, e.g., POLR2A, (3)
per-lane upper-quartile of gene counts for genes with
reads in at least one lane. In order to make the normal-
ized expression measures comparable, the scaling factors
are themselves scaled so that their sum across all lanes
is equal to the sum of the total counts across all 14
lanes (see [Additional file 2: Supplemental Section S4]).
The expression quantitation problem can be framed in
terms of generalized linear models (GLM),
log( [ | ]) log , ,( ) , , E Xd d ij i i ai j ij =++  (1)
where the natural logarithm of the expected value of
the read count Xi, j for the jth gene in the ith lane is
modeled as a linear function of the gene’se x p r e s s i o n
level la(i), j for the biological condition a(i) assayed in
lane i plus an offset (log di) and possibly other technical
effects (θi, j).
Finally, we propose a quantile normalization proce-
dure, inspired from the microarray normalization
approach of [18] and its implementation in the R pack-
age aroma.light. Specifically, for each lane, the distribu-
tion of read counts is matched to a reference
distribution defined in terms of median counts across
sorted lane. The normalized data are rounded to pro-
duce integer values that can be used with the DE statis-
tics described below.
Differential expression
We compare three types of methods for inferring DE,
each of which yields one test statistic per gene: Fisher’s
exact test statistic, likelihood ratio statistics based on a
generalized linear modela si nE q u a t i o n( 1 ) ,a n dt-sta-
tistics based on estimated parameters of the same
GLM. Two different t-statistics are evaluated, which
use different techniques for estimating the variance of
the estimated parameters. We also assess the impact of
flow-cell effects, either through the addition of para-
meters θi, j in the GLM or through a Mantel-Haenszel
test, an extension of Fisher’s exact test (see [Additional
file 2: Supplemental Section S5]). All of the considered
DE statistics can accommodate global normalization
via an offset di. For the GLM-based statistics, the offset
is handled as in Equation (1). Fisher’s exact test and
the Mantel-Haenszel test compare the distribution of
the counts of the jth gene to that of d.
The likelihood ratio statistics are the most general, as
they can be used for comparisons of any number of bio-
logical sample types and adjust for general experimental
effects as well as sample covariates, e.g., RNA quality.
The t-statistics are only applicable for testing differences
between two groups. The t-statistics and likelihood ratio
statistics are based on maximum likelihood estimators
from the same GLM, but have different performance in
certain cases. Distributional properties of all of the
GLM-based statistics are derived under asymptotic the-
ory; therefore, they may have poor behavior for small
numbers of input samples or low counts (though this is
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makes no assumption about sample size; however, it
only adjusts for global experimental effects and even the
Mantel-Haenszel extension allows only a single gene-
level experimental effect.
Likelihood ratio statistics have been used in [6] for the
special case of only a global lane effect (i.e., θi, j =0i n
Equation (1)); these authors also mentioned applying an
arcsine-root transformation for variance stabilization of
the per-gene read proportions within each lane. Bayesian
statistics with Gamma prior for the Poisson parameter
have been found to yield similar results as the above
GLM-based test statistics [19]. Other test statistics con-
sidered in the recent mRNA-Seq literature include t-sta-
tistics with square root-transformed standard errors and
Bayesian statistics based on the Beta-Binomial distribu-
tion [3].
Receiver operator characteristic curves using qRT-PCR
gold-standard
The qRT-PCR data of [13] are used as gold-standard to
determine “true” differential expression and derive recei-
ver operator characteristic (ROC) curves for various
mRNA-Seq and microarray DE methods. The qRT-PCR
estimate of UHR to Brain expression log-fold-change is
the difference of average expression measures for UHR
and Brain across replicates (see [Additional file 2: Sup-
plemental Section S6]).
We divide the genes assayed by qRT-PCR into three
sets, “non-DE”, “DE”,a n d“no-call”, based on whether
their absolute expression log-fold-change is less than a,
greater than b, or falls within the interval [a, b], respec-
t i v e l y .W ei g n o r et h e“no-call” genes when determining
true/false positives/negatives. True positives (TP) are
reported when the sequencing (or microarray) platform
not only correctly declares a gene DE, but also agrees
with qRT-PCR regarding the direction of DE. The true
positive rate (TPR) is then defined as the total number
of TPs divided by the total number of DE genes accord-
ing to qRT-PCR; the false positive rate (FPR) is com-
puted as usual. See Table 1 for a summary.
Software
In order to facilitate analysis and visualization of
mRNA-Seq data, we developed two R/Bioconductor
software packages, Genominator and GenomeGraphs






Comparison of mRNA-Seq differential expression statistics
Lists of differentially expressed genes are typically pro-
duced by computing, for each gene, a test statistic com-
paring expression levels between the two types of
biological samples and ranking the genes based on p-
values assessing the statistical significance of the
observed differences.
We evaluate various statistics for differential expres-
sion (see description in Methods, above) and find that
the main difference between test statistics is their ability
to handle low counts, an issue of great importance
when investigating differential expression in context of
mRNA-Seq. When both samples have zero reads, clearly
nothing can be said about differential expression. The
more pertinent zero-count or low-count scenario occurs
when a gene has zero reads for one sample and a rea-
sonable number for the other. Around 700 genes
(~1.8%) have zero reads in either Brain or UHR and 10
or more reads in the other tissue. Presumably, this
represents an interesting biological phenomenon, where
ag e n ei no n et i s s u ei sc o m p l e t e l yn o n - e x p r e s s e d
according to sequencing.
For genes with zero counts in either sample, the t-sta-
tistics fail: the estimated standard errors become extre-
mely large (or infinite in the case of the delta method t-
statistic) and the nominal p-values cluster around one,
regardless of the number of reads in the other sample.
For Fisher’se x a c tt e s ta n dt h eG L M-based likelihood
ratio test, however, we see a continuum of p-values as
desired. For genes with reasonable counts in both sam-
ples, the choice of test statistic makes little difference in
the nominal p-values ([Additional file 1: Supplemental
Figures S2 and S3]). Because they cannot stably handle
low-count genes, the t-statistics are failing to detect
many “easy” cases of DE (i.e., genes with large differ-
ences in expression between the two conditions) and, as
a result, have very low sensitivity. The poor performance
of the t-statistics is reflected in ROC curves (Figure 1).
Removal of genes with fewer than 20 reads in either
sample completely accounts for the poor sensitivity of
the t-statistics and results in equivalent ROCs for the
various DE statistics, all of which are dramatically
improved (Figure 1).
Table 1 Definition of true and false positive rates.
Synopsis of the rules for calling true/false positives and
negatives, which take into account the sign of the
direction of differential expression: “+” for over-
expression in UHR, “-” for over-expression in Brain.
mRNA-Seq
Non-DE DE + DE-
Non-DE TN FP FP N
qRT-PCR DE + FN TP FP P
DE- FN FP TP
The true positive rate (TPR) is estimated as TP/P and the false positive rate
(FPR) as FP/N.
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behavior, we will from here on focus only on the results
from the GLM-based likelihood ratio tests. The results
do not change when different test statistics are used,
except for the already noted poor performance of the
t-statistics for low-count genes.
Impact of technical effects on differential expression
Gene-length biases in differential expression
It is expected from the mRNA-Seq assay that longer
transcripts contribute more “sequencible” fragments
than shorter ones expressed at the same level. There is
clearly a positive association between gene counts and
length, an association that is not entirely removed via
scaling by gene length, as in the RPKM of [7] ([Addi-
tional file 1: Supplemental Figure S4]). This suggests
either higher expression among longer genes or non-lin-
ear dependence of gene counts on length.
As noted by [11], the dependence of gene counts on
length creates “gene length-related biases” in mRNA-
Seq DE results: longer genes tend to have more signifi-
cant DE statistics (Figure 2). All of the mRNA-Seq DE
statistics evaluated here have an inherent dependence of
their estimated standard errors on read counts. This is a
serious shortcoming in terms of creating “gene-lists” for
differential expression, as the resulting lists could favor
long genes with small underlying effects as compared to
short genes with large effects. Considering only esti-
mated fold-changes is inadequate, as this ignores the
fairly large range of standard errors for a given fold-
change and gene length.
O n ec a np o s s i b l yr e m e d yt h el e n g t hd e p e n d e n c eo f
DE statistics using a fixed number of bases from each
gene; repeating the DE analysis by randomly selecting
250 bp from each gene removes the association between
DE significance and length ([Additional file 1: Supple-
mental Figure S5]). This also indicates that the cause of
the association is the length of the gene and not differ-
ences in the underlying expression levels of longer
genes. However, a fixed-length analysis is unsatisfactory,
as it discards large amounts of data and there is no nat-
ural choice of common length.
A weighted analysis based on gene length might con-
stitute a reasonable compromise towards a length-inde-
pendent DE filter. Indeed, scaling each t-statistic by the
inverse of the square root of length provides a length-
independent ranking (Figure 2). However, the problem
of choosing a cutoff still remains. Under the assump-
tions presented in [11], with the unweighted t-statistics
and using the same cutoff across genes, power increases
with gene length for a given level of DE. Under the
same scenario, for the weighted t-statistics, both Type I
error rate and power decrease with length.
Impact of base-calling calibration method
The practice of reserving one lane out of eight, in each
flow-cell, for sequencing bacteriophage phi X genomic
DNA has important implications for experimental
design, in terms of sample size and balance. We find
that more reads are mapped to the genome with auto-
calibration than with the standard phi X calibration, at
each of three mapping stringency levels (Figure 3). Pur-
ity-filtered perfectly matching (FPM) reads are unlikely
to contain sequencing errors and can serve as proxies
for perfectly accurate reads. Similarly, purity-filtered
reads with either 0, 1, or 2 mismatches (FMM) are com-
prised of both FPM reads as well as reads that represent
Figure 1 Comparison of differential expression statistics: ROC curves. (a) All DE statistics, no gene filtering. (b) GLM-based likelihood ratio
statistics and t-statistics, before and after removing genes with fewer than 20 reads in either Brain or UHR. In both plots, a gene was declared
non-DE if its qRT-PCR absolute log-ratio was less than 0.2 and DE if its absolute log-ratio was greater than 2.0. Note that we require a true
positive to be differentially expressed in the same direction according to both mRNA-Seq and qRT-PCR (see Table 1 and Methods).
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Page 5 of 13Figure 2 Differential expression statistics, by length. Boxplots of the ranks of DE statistics vs. gene lengths for UI genes at least 250 bp-long
and with non-zero counts in both Brain and UHR. (a) Delta method t-statistics. (b) Delta method t-statistics weighted by the inverse of the
square root of gene length.
Figure 3 Impact of base-calling calibration method on read-mapping. Barplots of average read counts per lane with and without phi X
calibration, for each of the four biological sample (Brain, UHR) and flow-cell (F2, F3) combinations. Reads are classified into three nested
categories: purity-filtered perfectly matching reads (FPM); purity-filtered reads with either 0, 1, or 2 mismatches (FMM); unfiltered reads with
either 0, 1, or 2 mismatches (MM).
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can be viewed as a rough estimate of the sequencing
error rate, assuming no SNPs. For all lanes, the auto-
calibration method produces slightly lower error rates
(by ~5%).
The increased number of reads is spread unevenly
throughout the transcriptome. A majority of the UI
genes have no change in read counts between calibra-
tion methods, whereas around 25% of the genes have 4
or more additional reads when using auto-calibration.
When computing an (FMM-FPM)/FMM ratio for each
gene for both phi X and auto-calibration, auto-calibra-
tion yields lower error rates by about 3.8% on average.
The significance of differences in expression mea-
sures between the two calibration methods was evalu-
ated by comparing observed differences to a
permutation distribution of differences obtained by
randomly swapping the auto-calibrated and phi X-cali-
brated sets of read counts for each of the 14 lanes. We
find that in terms of absolute expression measures
there are small, but statistically significant differences
between the two calibration methods. However, rela-
tive expression measures, as used in DE analyses, do
not appear to be significantly different (see [Additional
file 2: Supplemental Section S8]).
Although our assessment is based on only two flow-
cells, it seems quite clear that auto-calibration is advan-
tageous, as it yields more balanced designs, frees up one
lane per flow-cell, and produces a larger number of
higher quality reads per lane.
Lane, flow-cell, and library preparation effects
The Poisson distribution has been shown to provide a
good fit to the distribution of gene-level counts across
replicate lanes, after normalization by total lane counts
[ 4 , 6 ] ;o u re x p e r i e n c ew i t hb o t ht h eM A Q Cd a t aa n d
unpublished datasets for Drosophila melanogaster sup-
ports this conclusion. The goodness-of-fit of the Poisson
model across different organisms and different sequen-
cing facilities strongly supports its validity as a model
for lane variation and justifies the pooling of read counts
across lanes by summation. Note, however, that the
applicability of the Poisson distribution is questionable
when analyzing biological replicates (i.e., samples from
different individuals within a given biological group,
such as, patients with the same type of cancer). The use
of negative binomial or empirical Bayes methods, as
described in the SAGE literature [21,22], may be sensi-
ble in such settings of increased variability.
Our analyses also confirm the previously noted small
technical differences between flow-cells [6], though
there is evidence of slightly more variation between
flow-cells than between replicate lanes ([Additional file
1: Supplemental Figure S6c]). Regardless of their statisti-
cal significance, estimated flow-cell effects are small in
magnitude and thus have a minor impact only in detect-
ing extremely small biological effects; almost none for
genes with more than 3 reads/lane.
To the best of our knowledge, there has been no pub-
lished examination of the technical variation introduced
during library preparation; replication of the library pre-
paration is both expensive and time-consuming. There
are clear library preparation effects on the total number
of reads ([Additional file 1: Supplemental Figure S1]).
After adjusting for differences in total lane counts, there
is evidence for increased variation across replicate
library preparations as compared to flow-cells and lanes
([Additional file 1: Supplemental Figure S6d]); however,
this increased variability is mainly due to high-count
genes for which there is high power to detect small dif-
ferences. A direct comparison of library preparation
effects to flow-cell and biological effects is not possible
due to the experimental design, but comparison of the
magnitude of the estimated differences suggests that
library preparation effects are much smaller than the
biological effects between Brain and UHR (Figure 4) and
slightly larger for some genes than flow-cell effects
(Figures 4 and [Additional file 1: Supplemental
Figure S6]).
The biological differences between Brain and UHR
samples may be much larger than those typically
observed; therefore, technical sources of variation need
not always be irrelevant. Finally, we note that the
Figure 4 Comparison of biological, library preparation, and
flow-cell effects. Boxplots of estimated log-fold-changes for UHR
vs. Brain biological effects (GLM 2 in [Additional file 2: Supplemental
Table S4]), flow-cell effects adjusting for biology (GLM 4), library
preparation effects within flow-cell (GLM 7). Estimates are presented
for total-count (black) and upper-quartile (blue) normalization.
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commercial-grade RNA was sequenced and (2) the
sequencing was performed in-house by Illumina. A typi-
cal mRNA-Seq experiment begins with the extraction of
RNA from biological specimens and variability induced
during extraction may be much larger than the technical
variability seen here.
Normalization of mRNA-Seq data
Because the total number of reads varies between lanes,
read counts must be normalized to allow comparison of
expression measures across lanes or samples. While this
subject has received relatively little attention in the
mRNA-Seq literature, the common practice is to scale
t h eg e n ec o u n t sb yl a n et o t a l s[ 6 , 7 ] .W ef i n d ,h o w e v e r ,
that more general quantile-based procedures yield much
better concordance with qRT-PCR and are hopefully
more robust than normalization by a single housekeep-
ing gene.
Here, we evaluate a variety of normalization proce-
d u r e sa n df o c u so nt w om a i nq u e s t i o n s :( 1 )D o e st h e
normalization improve DE detection (sensitivity)? (2)
Does the normalization result in low technical variability
across replicates (specificity)? To assess DE detection,
we rely on the qRT-PCR data of [13] as a gold-standard
for determining true and false positives. Because there
are a limited number of non-DE genes in the qRT-PCR
data, we also assess goodness-of-fit to the Poisson
model for replicate lanes (GLM 1 in [Additional file 2:
Supplemental Table S4]).
The simplest form of normalization is achieved by
scaling gene counts, in lane i, by a single lane-specific
factor di. In essence, these global scaling factors define
the null hypothesis of no differential expression: if a
gene has the same proportions of counts across lanes as
the proportions determined by the vector of di’s, then it
is deemed non-differentially expressed.
The standard total-count normalization results in low
variation across lanes, flow-cells, and library prepara-
tions, as discussed above. What has not been under-
stood previously, is that this normalization technique
reflects the behavior of a relatively small number of
high-count genes: 5% of the genes account for approxi-
mately 50% of the total counts in both Brain and UHR.
These genes are not guaranteed to have similar levels of
expression across different biological conditions and, in
the case of the MAQC-2 dataset, they are noticeably
over-expressed in Brain, as compared to the majority of
the genes (Figure 5).
Accordingly, the performance of total-count normali-
zation is not particularly impressive for detecting DE
(Figure 6): sensitivity is only slightly higher as compared
to the microarray data, even for genes with relatively
large differences in expression (> 2 absolute log-ratio).
When including genes with lower levels of differential
expression (> 0.5 absolute log-ratio), performance is no
better (and perhaps slightly worse) than that of microar-
rays. This contradicts general expectation given that the
mRNA-Seq data are less noisy and thus better at detect-
ing small expression differences. For small levels of DE,
the bias in estimated log-ratios using total-count nor-
malization makes the sequencing estimates less accurate.
We evaluate two alternatives for normalization of
mRNA-Seq data. One approach relies on a single
Figure 5 Impact of highly-expressed genes. (a) Cumulative percentage of total read count for Brain (green) and UHR (purple) samples,
starting with the gene with the highest read count (across the seven Brain or UHR lanes). Cumulative read counts are marked for the 5, 10, 20,
and 30 percent most highly expressed genes. (b) Running value of the UHR/Brain expression fold-change for unnormalized counts, starting with
the gene with the lowest total count across all 14 lanes. Horizontal lines correspond to: the ratio of the counts for all genes (black), the ratio of
the counts for the POLR2A gene (red), and the ratio of the per-lane upper-quartile of counts for genes with reads in at least one lane (blue).
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Page 8 of 13housekeeping gene like POLR2A, a standard technique
for normalizing qRT-PCR expression measures. How-
ever, this is not a feasible solution in general, since it is
not known a priori which genes have stable expression
levels (in [13], POLR2A was chosen only after examin-
ing many replicates for UHR and Brain across a number
of plates).
In analogy with standard techniques for normalizing
microarray data, we propose to match the between-lane
distributions of gene counts in terms of parameters such
as quantiles. For instance, one could simply scale counts
within lanes by their median. In our case, due to the
preponderance of zero and low-count genes, the median
is uninformative for the different levels of sequencing
effort. Instead, we use the per-lane upper-quartile (75th
percentile), after excluding genes with zero reads across
all lanes (see Methods).
Compared to total-count normalization, both POLR2A
and upper-quartile normalization significantly reduce
the bias of DE relative to qRT-PCR (Figure 7 and [Addi-
tional file 1: Supplemental Figure S7]), with upper-quar-
tile having bias near zero. ROC curves illustrate that
both upper-quartile and POLR2A normalization are
unequivocally better than total-count normalization at
detecting DE (Figure 6 and [Additional file 1: Supple-
mental Figure S8a]) and result in improved sensitivity of
sequencing relative to microarray data (Figure 6 and
[Additional file 1: Supplemental Figure S9]).
A closer look at technical variation for the different
normalization procedures shows that upper-quartile
normalization does not noticeably increase the level of
variability as compared to total-count normalization;
POLR2A normalization is slightly more variable but still
comparable (Figure 8).
Finally, it is also feasible to perform quantile normali-
zation across lanes, as is often done in microarray
experiments [23]. However, there does not seem to be
added benefit to this more complicated normalization
strategy. Quantile normalization performs similarly in
the ROC analyses (Figure [Additional file 1: Supplemen-
tal Figure S8a]) and induces comparable, or even slightly
more, variability than upper-quartile normalization
(Figure 8). We again recall the somewhat artificial nat-
ure of the MAQC data, which were obtained at essen-
tially the same time, by one lab, using ideal RNA
samples. As more data become available, there may be
larger variations in gene count distributions necessitat-
ing more aggressive normalization.
Conclusions
Our main novel finding is the extent to which normaliza-
tion affects differential expression results: sensitivity varies
more between normalization procedures, than between
test statistics. Although the standard total-count normali-
zation results in Poisson variation across replicate lanes,
it has poor detection sensitivity when benchmarked
against qRT-PCR. Instead, we propose scaling gene
counts by a quantile of the gene-count distribution (the
upper-quartile) and show that such normalization
improves sensitivity without loss of specificity.
A ni m p o r t a n ta s p e c to ft h eM A Q Cd a t a s e t s ,w h i c h
could have an impact on the interpretation of the
Figure 6 Comparison of mRNA-Seq and microarray differential expression calls to qRT-PCR: ROC curves. Genes common to all three
platforms and present for both qRT-PCR and sequencing (see [Additional file 2: Supplemental Section S6]). evaluated and declared DE if their
qRT-PCR absolute log-ratio was (a) greater than 2 or (b) greater than 0.5; genes were declared non-DE if their absolute log-ratio was less than
0.2. The GLM-based likelihood ratio test was used for the sequencing data. Two normalization procedures are presented for mRNA-Seq: total-
count (black) and upper-quartile (blue) normalization. Microarray data were normalized using RMA (gray). Note that we require a true positive to
be differentially expressed in the same direction according to both mRNA-Seq and qRT-PCR (see Table 1 and Methods).
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Page 9 of 13analyses presented, is the large difference in gene
expression between Brain and UHR. Often, gene
expression analyses consider much more closely
related sets of samples, with only relatively few genes
expected to be differentially expressed. In the compari-
son of Brain and UHR, by contrast, only 5-30% of
genes examined by qRT-PCR were deemed as non-dif-
ferentially expressed (depending on the choice of the
multiple testing procedure used to correct the p-
values). Indeed, there may be no truly non-DE genes
queried by the qRT-PCR experiment, but rather, very
small differences in expression for every gene. This
creates a possibility for errors when specifying a set of
true negatives; we have tried to control for this by a
careful and stringent definition of true negatives and
by evaluating the effect of changes in this definition
(see [Additional file 2: Supplemental Section S6]).
Furthermore, the extreme difference in transcriptional
profiles between the Brain and UHR samples means
that the p-values from the sequencing experiment are
smaller than would be expected if all the genes were
truly non-DE. In particular, the p-values for non-DE
genes (according to qRT-PCR) do not follow the
expected uniform distribution, but are noticeably shifted
toward zero ([Additional file 1: Supplemental
Figure S10]). The microarray data demonstrate the same
behavior ([Additional file 1: Supplemental Figure S10]),
suggesting it is caused by the samples under considera-
tion and not by inherent problems of the statistical
methods. In contrast to the qRT-PCR tests for
differential expression, the tests applied to sequencing
data take into account the total number of reads map-
ping to each gene and, as a result, tend to have greater
power for longer genes.
Another possible critique is that the improvement of
UQ over total-count normalization is due to this nor-
malizations more closely matching the normalization
procedure used with the qRT-PCR data rather than
proper reflection of actual biological differences; in
other words, UQ normalization might be closely match-
ing the effect of dividing by POLR2A, as is done with
the qRT-PCR data but not the underlying biology.
Indeed, additional scaling of the microarray data by
POLR2A slightly improves the ROC compared to the
standard microarray quantile normalization ([Additional
file 1: Supplemental Figure S8b]). It is more likely, how-
ever, that total-count normalization, with its reliance on
high-count genes, poorly reflects biological differences.
This can be seen by taking a closer look at the POLR2A
g e n e ,w h i c hw a sc h o s e na sar e f e r e n c ef o rq R T - P C R
data because of its very similar expression in UHR and
Brain across many qRT-PCR replicates [13]: the UHR to
Brain fold-change of POLR2A is estimated as 1.3 for
total-count normalization in contrast to 0.97 for upper-
quartile normalization and 0.90 for microarray data.
In regards to DE test statistics, the GLM-based likeli-
hood ratio statistics and Fisher’s exact statistics perform
equally well in terms of sensitivity and handling of low-
count genes. We find likelihood ratio tests appealing
because of their generality. Indeed, using the GLM
Figure 7 Comparison of mRNA-Seq and microarray differential expression measures to qRT-PCR. Difference scatterplots comparing the
estimates of UHR/Brain expression log-ratio from qRT-PCR to those from (a) mRNA-Seq, using the standard total-count normalization, and (b)
microarrays, using the standard RMA normalization. Shown are the genes shared between all three platforms, present in both Brain and UHR
according to both mRNA-Seq and qRT-PCR (see [Additional file 2: Supplemental Section S1]), and having absolute qRT-PCR expression log-ratio
less than 4. Horizontal lines in (a) represent the median UHR/Brain log-ratio for the sequencing data after the standard total-count normalization
(black), POLR2A normalization (red), quantile normalization (yellow), upper-quartile normalization (blue); horizontal lines in (b) show the median
UHR/Brain log-ratio for the microarray data after the standard RMA normalization (black) and POLR2A normalization (red).
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Page 10 of 13framework, one can adjust for potential confounding
variables, including quantitative covariates, e.g., age of
sample, as well as accommodate different count distri-
butions (negative binomial in cases of over-dispersion).
A serious concern with all the DE methods considered
here is the inherent dependence of power on read
count, which in turn is related to both gene expression
level and length. As most DE studies produce gene-lists,
which are often then related to functional annotation (e.
g., GO), it is undesirable for significance values to be
driven by features such as length. A weighted analysis
based on gene length might lead to a reasonable length-
independent ranking of genes, that would allow short
genes with large effects to gain in significance compared
to long genes with small effects.
We find that technical variation is quite low across
lanes and flow-cells and slightly larger across library
preparations. In all cases, however, the effect on differ-
ential expression results is minimal. As noted above, the
MAQC datasets are unusual, in that we expect extre-
mely large differences in expression between Brain and
UHR and only small library preparation effects because
of the high quality of the RNA. In practice, library pre-
paration effects may be closer in magnitude to biological
effects.
We have demonstrated that while there are some dif-
ferences between phi X and auto-calibration in the
early stages of the analysis pipeline, the differences in
terms of differential expression are small. Overall,
auto-calibration seems advantageous, as it yields more
Figure 8 Comparison of normalization procedures: Goodness-of-fit of Poisson model. The multiplicative Poisson model (GLM 1 in
[Additional file 2: Supplemental Table S4]) is fit to the seven Brain lanes in the MAQC-2 experiment after (a) total-count, (b) POLR2A, (c) upper-
quartile, and (d) quantile normalization. Goodness-of-fit statistics are computed and displayed in c
2 quantile-quantile plots. Genes with
goodness-of-fit statistics in the top quantiles of the c
2-distribution are displayed using colored plotting symbols: red (1, 5]%, purple (.1, 1]%, gold
[0, .1]%. Similar plots for UHR show the same patterns.
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Page 11 of 13balanced designs, frees up one lane per flow-cell, and
p r o d u c e sal a r g e rn u m b e ro fh i g h e rq u a l i t yr e a d s
per lane.
The analysis conducted in this work, as well as others,
is predicated on a “whole-gene” view of expression pro-
filing. We evaluated technical effects, phi X calibration,
and normalization methods using a very constrained UI
gene definition. We limited ourselves to such a strict
definition in order to ensure that the evaluation was not
biased by alternative splicing or overlapping genes. Our
UI gene definition is a gross over-simplification, as a
large amount of biologically relevant information is lost;
we exclude more than 50% of the reads which fall
within Ensembl genes.
As high-throughput sequencing becomes more pre-
valent, our ability to precisely characterize the tran-
scriptome of a sample will dramatically increase. More
refined analyses, such as isoform-level expression,
allele-specific expression, and genome annotation (seg-
mentation), involve comparing distinct regions within
a sample as opposed to the same region across sam-
ples. Such analyses will require an understanding of
the effect of sequence composition on base coverage to
account for the heterogeneity of base-level count
distributions
Additional file 1: Supplementary Figures File. Additional figures
referred to in the main article.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2105-11-
94-S1.PDF]
Additional file 2: Supplementary Text File. Additional text to describe
further details and results of the analysis.
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